SUCAMPO PHARMACEUTICALS INC's ticker is and the CUSIP is 864909AA4. A total of 28 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $2,732,000 | +32.2% | 2,250,000 | +12.5% | 0.02% | +33.3% |
| Q3 2017 | $2,066,000 | +5.8% | 2,000,000 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $1,953,000 | -1.3% | 2,000,000 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $1,979,000 | -7.1% | 2,000,000 | 0.0% | 0.01% | -7.7% |
| Q4 2016 | $2,130,000 | – | 2,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 12,000,000 | $14,670,000 | 8.68% |
| Worth Venture Partners, LLC | 1,878,000 | $2,292,000 | 2.54% |
| GABELLI FUNDS LLC | 2,250,000 | $2,732,000 | 0.02% |
| UBS Group AG | 3,500,000 | $4,250,000 | 0.00% |